OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...
A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.
The framework seeks to make the UK a desirable clinical trials location by expediting approvals and raising participant ...
The trial expansion was granted after RevBio demonstrated the safety of Tetranite in the first five treated patients.
An investigation published in The BMJ raises new concerns over the landmark clinical trial (PLATO) that was used to gain ...
Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who ...
As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...
RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...
A low-calorie, high-protein diet reduced anxiety and depression symptoms after 15 days and stress after 30 days in obese ...
Intercept Pharmaceuticals' liver disease drug is being observed for injury to the organ in patients without severe scarring, ...
For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive ...